Search results

Over the past 70 years ANSTO has been building Australia’s nuclear expertise and despite being small in scale, today we are complex and sophisticated nuclear nation.

New research published a team from the Imperial College London, University of Glasgow and ANSTO suggests that rock coasts, which make up over half the world’s coastlines, could retreat more rapidly in the future due to accelerating sea level rise.

Snapshots of an unprecedented double element-hydrogen bond activation at a transition metal centre.

NSTO’S major project to introduce eight new beamlines at the Australian Synchrotron has reached a milestone with the delivery of ‘first light’ to the new MEX-1 beamline.

An unassuming rock shelter in the Flinders Ranges has been revealed as the oldest known evidence of Aboriginal Australian settlement, thanks in part to advanced nuclear techniques, technology and scientists.

On the international stage amongst the leading nuclear nations of the world, Australians hold its own. This status has been earned by ANSTO’s seventy-year history of safe nuclear operations, the application of nuclear science and technology to benefit society and nuclear stewardship role in Australia.

ANSTO’s Centre for Accelerator Science measures extra-terrestrial plutonium in a study to clarify the origin of the heavier elements

A team of scientists from The Australian National University (ANU) has discovered how a powerful “weapon” used by many fungal pathogens enables them to cause disease in major food crops such as rice and corn

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

The 2023 Australian Synchrotron Stephen Wilkins Thesis Medal has been awarded to Dr Yanxiang Meng from the Walter & Eliza Hall Institute for Medical Research and the University of Melbourne for his research investigating the molecular mechanism at work in a form of programmed cell death, which is implicated in a variety of inflammatory diseases.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.